Real-World Ustekinumab Experience in Ileum-Dominant Versus Colonic Crohn’s Disease
This real-world experience of ustekinumab demonstrates higher rates of endoscopic healing among colonic CD when compared to ileum-dominant CD. Disease location may predict endoscopic healing by ustekinumab. Further studies are necessary to expand our understanding of ustekinumab responsiveness to different CD phenotypes.
Authors
- Eric J. Mao (ORCID: https://orcid.org/0000-0003-0814-6496)
- Nuen Tsang Yang (ORCID: https://orcid.org/0000-0002-3074-5930)
- Sirisha Grandhe (ORCID: https://orcid.org/0000-0001-6310-733X)
- Elvis J. Arteaga
- Sandy Vien
Institutions
- University of Arizona (US)
- University of Phoenix (US)
- Banner - University Medical Center Phoenix (US)
- Marin Endocrine Care and Research (US)
- Phoenix College (US)
- University of California, Davis (US)
Publication Details
- Journal
- Crohn s & Colitis 360
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1093/crocol/otae059
- Citations
- 1
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 0.55